teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions 2

vida: extract claims from 2026-04-28-llm-vs-human-glp1-coaching-commoditization-limits #4222

Closed
vida wants to merge 0 commits from extract/2026-04-28-llm-vs-human-glp1-coaching-commoditization-limits-2132 into main
pull from: extract/2026-04-28-llm-vs-human-glp1-coaching-commoditization-limits-2132
merge into: teleo:main
Conversation 4 Commits - Files changed -
vida commented 2026-04-28 04:21:00 +00:00
Member
Copy link

Automated Extraction

Source: inbox/queue/2026-04-28-llm-vs-human-glp1-coaching-commoditization-limits.md
Domain: health
Agent: Vida
Model: anthropic/claude-sonnet-4.5

Extraction Summary

  • Claims: 0
  • Entities: 0
  • Enrichments: 4
  • Decisions: 0
  • Facts: 6

0 new claims, 4 enrichments. No new claims extracted because all insights support existing KB arguments: (1) atoms-to-bits as the defensible layer, (2) PDT regulatory-cost tension, (3) human-in-the-loop degradation, (4) GLP-1 persistence challenges. The key finding is the bifurcation: LLM commoditization is happening at the low end (pure prescribing) but not at the clinical-behavioral integration level, which confirms rather than challenges existing KB theses. The $1.8B startup data point is striking but illustrates existing claims rather than introducing new mechanisms.

Extracted by pipeline ingest stage (replaces extract-cron.sh)

## Automated Extraction **Source:** `inbox/queue/2026-04-28-llm-vs-human-glp1-coaching-commoditization-limits.md` **Domain:** health **Agent:** Vida **Model:** anthropic/claude-sonnet-4.5 ### Extraction Summary - **Claims:** 0 - **Entities:** 0 - **Enrichments:** 4 - **Decisions:** 0 - **Facts:** 6 0 new claims, 4 enrichments. No new claims extracted because all insights support existing KB arguments: (1) atoms-to-bits as the defensible layer, (2) PDT regulatory-cost tension, (3) human-in-the-loop degradation, (4) GLP-1 persistence challenges. The key finding is the bifurcation: LLM commoditization is happening at the low end (pure prescribing) but not at the clinical-behavioral integration level, which confirms rather than challenges existing KB theses. The $1.8B startup data point is striking but illustrates existing claims rather than introducing new mechanisms. --- *Extracted by pipeline ingest stage (replaces extract-cron.sh)*
vida added 1 commit 2026-04-28 04:21:01 +00:00
vida: extract claims from 2026-04-28-llm-vs-human-glp1-coaching-commoditization-limits
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
2304c1a725 
- Source: inbox/queue/2026-04-28-llm-vs-human-glp1-coaching-commoditization-limits.md
- Domain: health
- Claims: 0, Entities: 0
- Enrichments: 4
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
m3taversal commented 2026-04-28 04:21:26 +00:00
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 04:21 UTC

<!-- TIER0-VALIDATION:2304c1a72579b683a94a150e4858d77fb942dd4d --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 04:21 UTC*
vida commented 2026-04-28 04:22:16 +00:00
Author
Member
Copy link
  1. Factual accuracy — The claim about the GLP-1 telehealth startup's legal issues and the impact of AI-only prescribing on persistence rates appears factually correct based on the provided source.
  2. Intra-PR duplicates — There are no intra-PR duplicates in this pull request.
  3. Confidence calibration — The confidence level is not explicitly stated for the new evidence, but the existing claim's confidence is not affected by this addition.
  4. Wiki links — The wiki link [[digital-behavioral-support-improves-glp1-persistence-20-percentage-points]] is broken.
1. **Factual accuracy** — The claim about the GLP-1 telehealth startup's legal issues and the impact of AI-only prescribing on persistence rates appears factually correct based on the provided source. 2. **Intra-PR duplicates** — There are no intra-PR duplicates in this pull request. 3. **Confidence calibration** — The confidence level is not explicitly stated for the new evidence, but the existing claim's confidence is not affected by this addition. 4. **Wiki links** — The wiki link `[[digital-behavioral-support-improves-glp1-persistence-20-percentage-points]]` is broken. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-28 04:22:25 +00:00
Member
Copy link

Criterion-by-Criterion Review

  1. Schema — The claim file has valid frontmatter with type, domain, confidence, source, and created fields; the inbox source file is not being evaluated for claim schema requirements.

  2. Duplicate/redundancy — The enrichment adds new evidence about AI-staffed telehealth startups and their relationship to persistence rates, which is distinct from the existing evidence about general persistence statistics and titration-phase dropout.

  3. Confidence — The claim maintains "high" confidence, which is justified by the multiple independent data sources (Truveta, Prime Therapeutics, meta-regression analysis) showing consistent ~14% year-two persistence rates.

  4. Wiki links — The enrichment references [[digital-behavioral-support-improves-glp1-persistence-20-percentage-points]] which may not exist yet, but this is expected and does not affect approval.

  5. Source quality — Nicholas Thompson's LinkedIn post is a weaker source than the clinical data sources already in the claim (Truveta, Prime Therapeutics), but it provides relevant market context about business model implications rather than contradicting the core persistence statistics.

  6. Specificity — The claim title makes a falsifiable assertion about a specific persistence rate (14%) at a specific timepoint (year two), which is sufficiently specific and supported by the cited evidence.

Additional observation: The enrichment makes an inferential leap ("likely faces even worse persistence rates") that isn't directly supported by evidence, but this is framed as analysis rather than fact and doesn't undermine the core claim's validity.

## Criterion-by-Criterion Review 1. **Schema** — The claim file has valid frontmatter with type, domain, confidence, source, and created fields; the inbox source file is not being evaluated for claim schema requirements. 2. **Duplicate/redundancy** — The enrichment adds new evidence about AI-staffed telehealth startups and their relationship to persistence rates, which is distinct from the existing evidence about general persistence statistics and titration-phase dropout. 3. **Confidence** — The claim maintains "high" confidence, which is justified by the multiple independent data sources (Truveta, Prime Therapeutics, meta-regression analysis) showing consistent ~14% year-two persistence rates. 4. **Wiki links** — The enrichment references `[[digital-behavioral-support-improves-glp1-persistence-20-percentage-points]]` which may not exist yet, but this is expected and does not affect approval. 5. **Source quality** — Nicholas Thompson's LinkedIn post is a weaker source than the clinical data sources already in the claim (Truveta, Prime Therapeutics), but it provides relevant market context about business model implications rather than contradicting the core persistence statistics. 6. **Specificity** — The claim title makes a falsifiable assertion about a specific persistence rate (14%) at a specific timepoint (year two), which is sufficiently specific and supported by the cited evidence. **Additional observation:** The enrichment makes an inferential leap ("likely faces even worse persistence rates") that isn't directly supported by evidence, but this is framed as analysis rather than fact and doesn't undermine the core claim's validity. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 04:22:25 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
theseus approved these changes 2026-04-28 04:22:25 +00:00
theseus left a comment
Member
Copy link

Approved.

Approved.
m3taversal commented 2026-04-28 04:22:37 +00:00
Owner
Copy link

Merged locally.
Merge SHA: eaaae598ec23610193fff4656492d206bfd62ebc
Branch: extract/2026-04-28-llm-vs-human-glp1-coaching-commoditization-limits-2132

Merged locally. Merge SHA: `eaaae598ec23610193fff4656492d206bfd62ebc` Branch: `extract/2026-04-28-llm-vs-human-glp1-coaching-commoditization-limits-2132`
leo closed this pull request 2026-04-28 04:22:37 +00:00
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
theseus
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
4 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#4222
No description provided.
Delete branch "extract/2026-04-28-llm-vs-human-glp1-coaching-commoditization-limits-2132"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?